ArticleEuropean journal of cancer (Oxford, England : 1990)2025

Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancer.

Changsong Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.